Skip to main content
CDC Website

Physicians

Scale up of HIV-Related Prevention, Diagnosis, Care and Treatment for Infants and Children: A Programming Framework

This monograph provides a programming framework to assist national health managers and implementing partners in resource-constrained settings that have a high burden of HIV. The monograph gives information about scaling up HIV prevention, and the diagnosis, care, and treatment for children exposed to, or infected with, HIV. The framework emphasizes the importance of early HIV diagnosis, cotrimoxazole preventive treatment for children who are exposed to, or who are infected with, HIV, and timely entry to care and treatment.

Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis

This report presents the Centers for Disease Control and Prevention's (CDC) updated recommendations on the use of nucleic acid amplification tests (NAA) for TB diagnosis. These revised guidelines were developed on the basis of a report by a panel of clinicians, laboratorians, and TB control officials. The panel was convened by CDC and the Association of Public Health Laboratories (APHL) and in consultation with the Advisory Council for the Elimination of TB (ACET).

Memento Therapeutique du VIH/SIDA en Afrique

This report is a manual on antiretroviral treatment and care of HIV infected patients in African settings. This second version of the manual was written by a team of doctors and researchers in France. It provides concise updated information on types of antiretroviral drugs, post-exposure prophylaxis, treatment recommendations, infant formulations, generics, and treatment of opportunistic infections.

Diabetes Mellitus and HIV

This visual file consists of 37 slides on the medical case management of diabetes mellitus and HIV. It explains the two types of diabetes, the class of HIV drugs that cause kidney problems or worsening of diabetes, the symptoms of peripheral neuropathy, and effective treatment. The online link can be found at http://aidsetc.org/aidsetc?page=etres-display&resource=etres-529.

Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011

On October 25, 2011, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of quadrivalent human papillomavirus (HPV) vaccine (HPV4; Gardasil, Merck & Co. Inc.) in males aged 11 or 12 years. ACIP also recommended vaccination with HPV4 for males aged 13 through 21 years who have not been vaccinated previously or who have not completed the 3-dose series; males aged 22 through 26 years may be vaccinated. These recommendations replace the October 2009 ACIP guidance that HPV4 may be given to males aged 9 through 26 years.

MMWR: Vital Signs: HIV Infection, Testing, and Risk Behaviors Among Youths - United States

In this report, the CDC used the National HIV Surveillance System data to estimate among youths, prevalence rates of diagnosed HIV infection in 2009 and the number of new infections in 2010. CDC used the 2009 and 2010 Youth Risk Behavior Surveillance System for 9th -12th grade students and the 2010 National Health Interview Survey for persons 18-24 years. Prevalence of diagnosed HIV was 69.5 per 100,000 youths at the end of 2009. Youth accounted for 12,200 (25.7 percent) new HIV infections in 2010.